AVAI BIO, INC. - 10-Q Filing

Avai Bio, Inc. reports Q3 2026 net loss of $253,240 and total stockholders' deficit of $3.41B as cash reserves reach $121,948.

SEC EDGAR · November 13, 2026, 16:57 UTC

Tickers: $AVAI

Part of the story BIO-TECHNE Corp - 10-Q Filing (3 articles)

More Regulatory news

Yinfu Gold Corp. - 10-Q Filing SEC EDGAR · November 13, 2026, 17:17 UTC
CROSS TIMBERS ROYALTY TRUST - 10-Q Filing SEC EDGAR · November 13, 2026, 17:14 UTC
INTEGRATED BIOPHARMA INC - 8-K Filing SEC EDGAR · November 13, 2026, 17:12 UTC
Rare Earths Americas, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 17:00 UTC
DYADIC INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 13, 2026, 16:57 UTC
INTEGRATED BIOPHARMA INC - 10-Q Filing SEC EDGAR · November 13, 2026, 16:52 UTC
PCS Edventures!, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:49 UTC
Royale Energy, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:46 UTC
Blue Chip Capital Group Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 16:34 UTC
MOVING iMAGE TECHNOLOGIES INC. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:28 UTC